Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Podoplanin as a marker for mesothelioma

View through CrossRef
Podoplanin is a specific marker for lymph vessel endothelial cells. It was noted that podoplanin is expressed in reactive mesothelial cells. The utility of podoplanin for the histological diagnosis of tumors was then investigated, especially for mesothelioma. Immunohistochemical study of podoplanin was carried out in five malignant mesotheliomas and 118 other tumors including 93 adenocarcinomas, four squamous cell carcinomas, six gastrointestinal stromal tumors and five endocrine tumors. Immunoreactivity for podoplanin was demonstrated on the cell membrane of tumor cells for all mesotheliomas. All other tumors were negative for podoplanin. Among the many antibodies used for differential diagnosis of malignant mesothelioma, podoplanin has the potential to be an excellent tumor marker in both specificity and sensitivity. The utility of podoplanin as a marker for mesothelioma will be confirmed by further studies.
Title: Podoplanin as a marker for mesothelioma
Description:
Podoplanin is a specific marker for lymph vessel endothelial cells.
It was noted that podoplanin is expressed in reactive mesothelial cells.
The utility of podoplanin for the histological diagnosis of tumors was then investigated, especially for mesothelioma.
Immunohistochemical study of podoplanin was carried out in five malignant mesotheliomas and 118 other tumors including 93 adenocarcinomas, four squamous cell carcinomas, six gastrointestinal stromal tumors and five endocrine tumors.
Immunoreactivity for podoplanin was demonstrated on the cell membrane of tumor cells for all mesotheliomas.
All other tumors were negative for podoplanin.
Among the many antibodies used for differential diagnosis of malignant mesothelioma, podoplanin has the potential to be an excellent tumor marker in both specificity and sensitivity.
The utility of podoplanin as a marker for mesothelioma will be confirmed by further studies.

Related Results

Podoplanin-mediated platelet activation promotes proliferation and invasion of colon cancer cells
Podoplanin-mediated platelet activation promotes proliferation and invasion of colon cancer cells
Abstract Background: Recent studies have shown that podoplanin is highly expressed in many tumors, suggesting that podoplanin may be related to the invasion and metastasis ...
Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma
Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma
Background. Recent studies have demonstrated that podoplanin was expressed in some dysplastic lesions adjacent to primary oral cancers suggesting that podoplanin expression may occ...
Abstract 1599: Capture of tumor cells in blood with "Universal CTC-chip"
Abstract 1599: Capture of tumor cells in blood with "Universal CTC-chip"
Abstract Background: Circulating tumor cells (CTCs) are not only a surrogate of distant metastasis, but also useful for material of liquid biopsy. "Universal" CTC-ch...
Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors
Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors
AbstractPurpose: CD26 is a 110-kDa cell surface antigen with a role in tumor development. In this report, we show that CD26 is highly expressed on the cell surface of malignant mes...
Peritoneal Mesothelioma: Clinical and Therapeutic Aspects
Peritoneal Mesothelioma: Clinical and Therapeutic Aspects
Mesothelioma is a very rare malignant disease that originates from mesothelial cells that line the serosa: pleura, peritoneum, pericardium, or testicular vaginal tunic. Peritoneal ...
Malignant Mesothelioma In Situ: A Controversial Diagnostic Entity – A Review
Malignant Mesothelioma In Situ: A Controversial Diagnostic Entity – A Review
Malignant mesothelioma is a rare aggressive malignancy of serosal surfaces that is strongly associated with exposure to asbestos. The pathological diagnosis of malignant mesothelio...
Abstract 210: Novel antibody drug conjugate to inhibit mesothelioma tumor growth
Abstract 210: Novel antibody drug conjugate to inhibit mesothelioma tumor growth
Abstract Mesothelioma is an aggressive but rare form of cancer with a poor prognosis. 1-year survival is ~40% and 5-year survival remains in single digits. Treatment...
A Surprising Finding of Ileal Intussusception Caused by Pleural Mesothelioma Metastases
A Surprising Finding of Ileal Intussusception Caused by Pleural Mesothelioma Metastases
Background: Malignant pleural mesothelioma is an aggressive form of cancer originating in the pleural mesothelioma. It generally appears as a local disease in the affected hemithor...

Back to Top